patent/MX-2017016423-A

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0d51806567d8f1e090d1507c5f6dd3a
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1611 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
filingDate	2016-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f03d0ff5527656e1954b9b4ef1c3425
publicationDate	2018-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	MX-2017016423-A
titleOfInvention	ZOLMITRIPTAN POWDER FOR PULMONARY SUPPLY.
abstract	The invention provides stable, spray-dried particle formulations containing a triptan, preferably sumatriptan, or a pharmaceutically acceptable salt thereof, useful for pulmonary administration in the respiratory tract of a patient to treat a disease.
priorityDate	2015-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743214 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506650

Total number of triples: 21.